AI in Biotech - Show & Tell
Come join us to compare notes on Al tools, workflows, failed experiments, surprising wins, and what's still mostly hypе in biotech!
For biotech founders, operators, and fellow biotech builders navigating the glorious chaos of Al.
Open discussions about what works and what doesn't in the lab.
No pitching, no polished theatre. Just honest conversation about the strange new powers of Al, minor victories, noble failures, and what may yet save us all a few months of suffering!
Date: April 8
Time: 5:00 PM – 8:00 PM
5:00 - 6:00pm: Doors Open and Networking
6:00 - 6:05: Introduction
6:05 - 6:10: MBC Biolabs Welcomes
6:10 - 7:30pm: Panel, Show & Tell, Discussion
7:30 - 8:00: Networking
Panelists and Key Show & Tell:
Parag Mallik - Founder at Nautilus Biotechnology; Associate Professor at Stanford University
Dr. Parag Mallick is an Associate Professor at Stanford University, and also Founder & Chief Scientist at Nautilus Biotechnology. Originally trained as an engineer and biochemist, Dr. Mallick’s group has been pioneering multi-omic and systems-biology approaches towards understanding disease mechanisms, discovering biomarkers and enabling personalized medicine. His group has also been pioneering meaningful machine learning methods that have more interpretable and accurate explanations and can be trained with smaller amounts of input data. Dr. Mallick has over 100 publications and holds patents in the fields of artificial intelligence, proteomics technology, biomarker development, and nanotechnology.
Eeshit Dhaval Vaishnav - Founder & CEO at Sequome
Eeshit Dhaval Vaishnav is the Founder & CEO of Sequome, a company that engineers biological sequences to develop therapeutics, working with Fortune 500 Pharmaceutical & Technology companies. Prior to Sequome, Eeshit received his PhD from MIT as a Presidential Fellow, where he was advised by Prof. Aviv Regev (currently Head of Roche gRED), and collaborated with leading institutions in academia (Broad Institute) and industry (Google). Eeshit led the development of Gene Genie, the sequence→function AI for decoding & designing sequences, published on the cover of Nature.
Sasha Denisin - Principal Product Manager for Lab Automation Software at Genentech
Sasha Denisin works at the intersection of robotics and software to revolutionize drug discovery by developing products that enable AI/ML applications and lab-in-the-loop systems. Sasha brings deep technical experience to this role, having previously served as a hands-on engineer and team lead building automated workflows for both clinical diagnostics and therapeutics development. A trained bioengineer, she holds a PhD from Stanford and a BS from UC Berkeley.
Jens Kortmann - Principal & Founder at Kortmann BioAdvisory
Jens Kortmann is a scientist and founder of Kortmann BioAdvisory, working at the intersection of neuroimmune biology and AI. He develops human-in-the-loop AI workflows (Hypotheon™) to structure complex disease biology and guide where experimental effort should focus, with experience spanning Genentech and Stanford.
Who should apply
People building or operating in biotech and related life science workflows.
About Sierra Nights:
Sierra Nights is an event series for the parts of biotech that don’t show up on slides. The gaps people are dealing with, the tools they’re actually using, and the signals worth paying attention to. No pitching. No marketing. Just real conversations.
About MBC BioLabs:
MBC BioLabs, flexible lab-space for ambitious biotech companies tackling today’s biggest challenges. Learn more at www.mbcbiolabs.com